Cancer Immunotherapy Named Science Magazine's "Breakthrough of the Year"
T cells(orange) attached to a tumor cell
Memorial Sloan-Kettering researchers have played a leading role in pioneering the scientific achievements behind what Science magazine has designated the "Breakthrough of the Year": cancer immunotherapy. Innovative treatments pioneered by MSKCC researchers harness the ability of T cells to recognize and destroy cancer cells. Memorial Sloan-Kettering Cancer Center development@mskcc.org. I hope that you can get more of information from this web.